Amy C. Peterson - Feb 26, 2025 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
EVP Prod Dev & Med Aff & CMO
Signature
/s/ Nina Ayer, Attorney in Fact
Stock symbol
EXEL
Transactions as of
Feb 26, 2025
Transactions value $
$0
Form type
4
Date filed
2/28/2025, 08:34 PM
Previous filing
Nov 19, 2024
Next filing
Mar 31, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Award $0 +52.2K +17.7% $0.00 347K Feb 26, 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F2 The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2026 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested.
F3 Includes 314,313 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs.